FDA Approved: OLOPATADINE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for olopatadine (ANDA206306) submitted by Somerset Therapeutics, LLC. The snippet indicates a supplemental approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• OLOPATADINE (OLOPATADINE)

Snippet

SUPPL AP for OLOPATADINE (OLOPATADINE)